2-Apr-2026
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
TipRanks (Mon, 30-Mar 7:31 PM ET)
Market Chameleon (Fri, 20-Mar 5:59 AM ET)
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
Globe Newswire (Thu, 19-Mar 4:05 PM ET)
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Assembly Biosciences trades on the NASDAQ stock market under the symbol ASMB.
As of April 2, 2026, ASMB stock price declined to $29.01 with 37,840 million shares trading.
ASMB has a beta of 1.48, meaning it tends to be more sensitive to market movements. ASMB has a correlation of 0.16 to the broad based SPY ETF.
ASMB has a market cap of $460.18 million. This is considered a Small Cap stock.
Last quarter Assembly Biosciences reported $42 million in Revenue and $1.30 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $2.01.
In the last 3 years, ASMB traded as high as $39.71 and as low as $7.69.
The top ETF exchange traded funds that ASMB belongs to (by Net Assets): VTI, VXF, IWC, AVSC, BBC.
ASMB has outperformed the market in the last year with a price return of +208.9% while the SPY ETF gained +18.2%. However, in the short term, ASMB had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.7% vs -3.6% return in SPY. But in the last 2 weeks, ASMB shares have fared better than the market returning +5.4% compared to SPY -0.6%.
ASMB support price is $28.35 and resistance is $30.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASMB shares will trade within this expected range on the day.